These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 10598925)
1. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. Seemann MD; Beinert T; Fürst H; Fink U Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions. Seemann MD; Seemann O; Dienemann H; Schalhorn A; Prime G; Fink U Eur J Med Res; 1999 Aug; 4(8):313-27. PubMed ID: 10471543 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Lee JH; Chang JH Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887 [TBL] [Abstract][Full Text] [Related]
4. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE. Ebert W; Hoppe M; Muley T; Drings P Anticancer Res; 1997; 17(4B):2875-8. PubMed ID: 9329552 [TBL] [Abstract][Full Text] [Related]
5. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China. Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515 [TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Kulpa J; Wójcik E; Reinfuss M; Kołodziejski L Clin Chem; 2002 Nov; 48(11):1931-7. PubMed ID: 12406978 [TBL] [Abstract][Full Text] [Related]
7. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer. Bates J; Rutherford R; Divilly M; Finn J; Grimes H; O'Muircheartaigh I; Gilmartin JJ Eur Respir J; 1997 Nov; 10(11):2535-8. PubMed ID: 9426091 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Barlési F; Gimenez C; Torre JP; Doddoli C; Mancini J; Greillier L; Roux F; Kleisbauer JP Respir Med; 2004 Apr; 98(4):357-62. PubMed ID: 15080079 [TBL] [Abstract][Full Text] [Related]
10. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma. Huang MS; Jong SB; Tsai MS; Lin MS; Chong IW; Lin HC; Hwang JJ Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852 [TBL] [Abstract][Full Text] [Related]
11. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Pujol JL; Boher JM; Grenier J; Quantin X Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules]. Ni LF; Liu XM Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391 [TBL] [Abstract][Full Text] [Related]
13. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules. Li X; Zhang Q; Jin X; Cao L World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454 [TBL] [Abstract][Full Text] [Related]
14. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
15. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer. Wang P; Piao Y; Zhang X; Li W; Hao X Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141 [TBL] [Abstract][Full Text] [Related]
16. [CYFRA 21-1: a new marker of epidermoid cancer of the bronchi. Comparison with 3 other markers]. Pujol JL; Grenier J; Ray P; Gautier V; Aouta MD; Michel FB Presse Med; 1993 Jun; 22(22):1039-42. PubMed ID: 7692432 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of conventional tumor markers in young patients with pulmonary nodules. Xu L; Su Z; Xie B J Clin Lab Anal; 2021 Sep; 35(9):e23912. PubMed ID: 34296781 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer. Giovanella L; Ceriani L; Bandera M; Beghe B; Roncari G Int J Biol Markers; 1995; 10(3):156-60. PubMed ID: 8551058 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers in the lung cancer diagnosis: a clinical perspective. Li X; Asmitananda T; Gao L; Gai D; Song Z; Zhang Y; Ren H; Yang T; Chen T; Chen M Neoplasma; 2012; 59(5):500-7. PubMed ID: 22668014 [TBL] [Abstract][Full Text] [Related]
20. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]